The Effect of Hybrid Simulation on Evaluating Neonatal Jaundice

January 3, 2023 updated by: Aylin PEKYİGİT, Çankırı Karatekin University

The Effect of Hybrid Simulation on Nursing Students' Ability to Evaluate Neonatal Physiological Jaundice: A Randomized Controlled Trial

This study will be conducted as a single-blind randomized control group intervention trial to determine the effectiveness of the hybrid simulation method using standard patient and low-fidelity baby simulators in the intervention of nursing students for neonatal physiologic jaundice.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Çankiri, Turkey, 18200
        • Recruiting
        • Çankırı Karatekin Üniversitesi
        • Contact:
          • Aylin Pekyiğit
          • Phone Number: 05413528050

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 27 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Enrolled in the course
  • Had not taken this course before
  • Accepted to participate in the research

Exclusion Criteria:

  • Have any records of absence
  • Taken this course before
  • Graduate of health vocational high school

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention/Treatment
In the implementation process of the research, knowledge tests will be applied as pre-test and post-test, and training will be given to the mother who has a baby with physiological jaundice. In the study, the scenario of the mother with a baby with jaundice will be implemented only with the intervention group
A mother scenario with a baby with physiological jaundice will be implemented with the intervention group.
No Intervention: Control
During the application process of the research, knowledge tests will be applied as pre-test and post-test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Student Information Form and First Knowledge Test
Time Frame: One week before Simulation (First week)

Student Information Form (First Knowledge Test-Before Simulation): In this form, which was created by the researcher by scanning the literature, did he choose the student's number, age, gender, graduated high school, nursing department willingly, did he get information about the simulation before, did he get information about neonatal jaundice? ? The questions are included. In the same survey, there is the "Newborn Physiological Jaundice Assessment Test" consisting of 25 questions created by the researchers. In this questionnaire, there are statements regarding the physiological jaundice of the newborn. Students were asked to mark one of the options "Yes", "No" or "I don't know" for these statements. This form was applied to the students as a pre-test. After the pretest, the subject was explained about the physiological jaundice of the newborn.

This form was filled by both the experimental and control groups.

One week before Simulation (First week)
Jaundice case checklist form
Time Frame: During simulation (Second week)
Jaundice case checklist form (During simulation): This checklist was created by the researcher. There are statements for learning objectives set to evaluate neonatal jaundice. These expressions are "did", "did not" and "partially did". The behavior of the student during the simulation was evaluated by the researcher and his peers. After the simulation, the student was asked to evaluate himself on this form and fill out the form.
During simulation (Second week)
Second Student Knowledge Test
Time Frame: Two weeks after simulation (Fourth week)
Second Student Knowledge Test (After the Simulation): 2 weeks after the simulation application, the "Newborn Physiological Jaundice Assessment Test" was applied to both the control and experimental groups. In addition to this test, "Student Satisfaction and Self-Confidence Scale in Learning" and "Simulation Design Scale" were applied to the experimental group.
Two weeks after simulation (Fourth week)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Müjgan Onarıcı, Çankırı Karatekin University
  • Study Chair: Tuğba Yıldırım, Çankırı Karatekin University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2022

Primary Completion (Actual)

December 20, 2022

Study Completion (Anticipated)

March 31, 2023

Study Registration Dates

First Submitted

December 5, 2022

First Submitted That Met QC Criteria

January 3, 2023

First Posted (Estimate)

January 10, 2023

Study Record Updates

Last Update Posted (Estimate)

January 10, 2023

Last Update Submitted That Met QC Criteria

January 3, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • CKU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nursing Education

Clinical Trials on simulation training

Subscribe